Clinical Trial Update: An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravenous palonosetron given as an infusion versus a bolus for prevention of chemotherapy-induced nausea and vomiting. The study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aloxi (palonosetron hydrochloride)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Chemotherapy-Induced Nausea and Vomiting | Phase 3 | Status: COMPLETED | Results posted: 2018-06-20